Allantoin and hydantoin as new protein aggregation suppressors
- 1 July 2018
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 114, 497-503
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Comfrey: A Clinical OverviewPhytotherapy Research, 2012
- High-resolution X-ray analysis reveals binding of arginine to aromatic residues of lysozyme surface: implication of suppression of protein aggregation by arginineProtein Engineering, Design and Selection, 2010
- Indispensable structure of solution additives to prevent inactivation of lysozyme for heating and refoldingBiotechnology Progress, 2009
- Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)Drug Discovery Today, 2007
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- Protein folding and misfoldingNature, 2003
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Preparation and fungicidal activity of 5-substituted hydantoins and their 2-thio analogsJournal of Agricultural and Food Chemistry, 1993
- The use of silver-zinc-allantoin powder for the prehospital treatment of burnsJournal of the American College of Emergency Physicians, 1977